Asia stocks slip tracking Wall St slide, set for monthly gains; Tokyo CPI in focus

Rhythm Pharmaceuticals (NASDAQ:RYTM) announced that the U.S. Food and Drug Administration has approved IMCIVREE (setmelanotide) for patients with acquired hypothalamic obesity, according to executives on a company conference call held following the approval news. FDA approval and label details Chie Source link

Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) was the target of a large drop in short interest in January. As of January 15th, there was short interest totaling 78,955,359 shares, a drop of 25.1% from the December 31st total of 105,368,569 shares. Based on an average trading volume of 40 shares, the short-interest ratio is…